Day One Wednesday 29 February 2012

Day One Wednesday 29 February 2012 ›

Day Two Thursday 1 March 2012 ›

last modified: 07 March '12

Please enable javascript to see more information on speakers

8.30am

Registration and coffee

8.50am

Opening remarks from the Chair

Mr Guy Clark

Guy joined Goldshield in August 2010 as Business Development Director, with responsibility for strengthening the strategic development of this UK-based specialty pharma company. The company was acquired by a Private Equity firm (HgCapital) in...

more..

› Mr Guy Clark, Business Development Director, Goldshield Group Limited

STRATEGIC OVERVIEW

9am

Generic medicines health check – view from the investment community

Dominic Hollamby

Dominic is a Vice Chairman of Rothschild in London and also holds the position of Global Head of Healthcare. He has been at Rothschild since 1998. As an experienced M&A practitioner focused on the healthcare industry, he has a long track record of ...

more..

• Current trends in M&A Pharma and generics
• Big Pharma and generics convergence
• Impact of health economics and budgetary pressure

› Dominic Hollamby, Vice Chairman, Rothschild

9.30am

The sustainability of generics industry: rethinking the future

Dr Brian Tempest

Dr Brian Tempest advises Companies, Banks, Investment Funds, Private Equity & High Net Worth Individuals on their Strategy in Asia based on his wide experience in China, Japan, South East Asia and India where he has lived for the last decade. Brian...

more..

› Dr Brian Tempest, Chairman, Hale & Tempest

10am

Speed Networking and Morning Refreshments

11am

Affordable Medicine Strategy- Building Value and Successful Generics Portfolio in an increasing competitive market

Anish Mehta

ANISH MEHTA has been with Watson Pharmaceuticals for 2 years and serves as the Vice President of European Generics. In this role, he is responsible for managing and growing Watson’s European Generics business. Prior to joining...

more..

› Anish Mehta, Vice President European Generics, Watson

11.30am

Growing your market share and expanding into new markets

Ashish Menocha

Accomplished Pharmaceutical Professional with more than fifteen years of Global Pharmaceutical Marketing and Management experience. Proficient in all areas relating to Pharmaceutical business with a successful performance record throughout. First...

more..

• Consolidate in existing markets vs grow in new markets
• Concept of pharmerging markets
• Growing centralised market access routes – MRP, GCC, CIS customs union
• Challenges of expansion
• Portfolio design for expansion – do you grow with all your products or selective portfolio

› Ashish Menocha, Head of International Markets, Abdi Ibrahim

12pm

Differentation in Generics

Rahul Garella

Rahul Garella is an experienced pharmaceutical executive with more than fifteen years of experience in the pharmaceutical business across the segments of Active pharmaceutical ingredients (APIs) and generic formulations. He currently heads up the...

more..

› Rahul Garella, Senior Vice President - EU Business, Glenmark Generics

12.30pm

Patient Strategies and Litigation Landscape

Dr Aman Trehan

Dr. Aman Trehan is head of Global Intellectual Property at Pharmaceutical Technology Centre of Zydus Cadila Healthcare Ltd. He obtained his doctorate in Pharmaceutical Sciences from Panjab University, India. He has worked in various multinational...

more..

› Dr Aman Trehan, General Manager and Head Glonal Intellectual Property, Zydus Cadila

1pm

Lunch

POLICY REVIEW

2pm

Keynote: Congressional update and Q&A session on US legislation on generics

Henry Waxman

Representative Henry A. Waxman represents California's 30th Congressional District, which includes the cities of Santa Monica, Beverly Hills, Agoura Hills, Calabasas, Hidden Hills, Malibu, Westlake Village and West Hollywood, as well as such areas...

more..

› Henry Waxman, Member of Congress, Congress- United State of America

2.30pm

Update of US Legislation Impacting Generics

Juliana Reed

Juliana Reed is the Vice President of Government Affairs for Hospira, Inc where she has overall responsibility for the Government Relations function which includes the oversight of global government relations and public policy initiatives for the...

more..

• Update on the implementation of healthcare reform • Prospects for health care legislation this year

› Juliana Reed, Vice President, Government Affairs, Hospira Inc

3pm

Recent developments in EU Competition Policy

Paul Csiszar

After graduating from ELTE School of Law of Budapest, Paul Csiszár studied international comparative law and earned a second JD at Loyola Law School in the United States. Following his admission to the bar in 1986 in California he practiced as a...

more..

• Monitoring and enforcement exercise • Patent settlements • European competition law

› Paul Csiszar, Competition Directorate General Director, Basic Industries, Manufacturing and Agriculture, European Commission

3.30pm

Afternoon refreshments

IP DEVELOPMENTS

4pm

Building a successful Business- A leaders view

Rex Clements at World Generic Medicines Congress Europe 2012

› Rex Clements, Chief Executive Officer, Sandoz UK

4.30pm

Purchasers perspective on cost containment and generic prescribing in Germany

Dr Cornelius Erbe

Dr. Cornelius Erbe is currently holding a position as senior vice president and member of the extended Board of Deutsche Angestellten-Krankenkasse (DAK); Hamburg/Germany. DAK is the third largest German statutory health insurance organization with...

more..

• A German payer's perspective on cost containment and generic prescribing • Actual situation in Germany - legal framework and market conditions • AMNOG: The impact on pricing procedures • Strategic positioning of DAK

› Dr Cornelius Erbe, Member of the Extended Board - Head of Product Management, DAK

5pm

Review of market dynamics in Germany and the opportunities and treats from tenders

Michael Ewers

Since November 2008 Michael Ewers is Managing Director/CEO of betapharm Arzneimittel GmbH in Augsburg, which is a subsidiary of the international pharmaceutical company Dr. Reddy's Laboratories, headquartered in Hyderabad, India. Ewers started his...

more..

• Market dynamics in generics in Germany • Implementation of tender contracts • Consequences for the German Generic industry

› Michael Ewers, CEO & Managin Director, betapharm Arzneimittel GmbH

5.30pm

Closing remarks from the Chair

5.35pm

Networking Drinks Reception

7.30pm

The World Generic Medicine Congress Gala Dinner is an opportunity to relax and network over a few drinks and enjoy great food with your fellow attendees.

Hear a truly inspirational speech from Pete Goss MBE. It’s a great story; during the yacht race Pete ended up rescuing a Frenchman deep in the southern ocean on Christmas day and a month later had to operate on himself in the Pacific Ocean. It’s interesting, funny, moving and very motivational. Pete loves what he does and looks forward to sharing one of his favourite adventures with you. (Please note this is an additional cost)

Get the World Generic Medicines Congress Europe 2012 brochure ›

Day One Wednesday 29 February 2012 ›

Day Two Thursday 1 March 2012 ›

last modified: 07 March '12